0001140361-15-035079.txt : 20150915
0001140361-15-035079.hdr.sgml : 20150915
20150915162012
ACCESSION NUMBER: 0001140361-15-035079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150911
FILED AS OF DATE: 20150915
DATE AS OF CHANGE: 20150915
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murray Mark J.
CENTRAL INDEX KEY: 0001628383
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 151107936
MAIL ADDRESS:
STREET 1: C/O TEKMIRA PHARMACEUTICALS CORP
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
4
1
doc1.xml
FORM 4
X0306
4
2015-09-11
0
0001447028
Arbutus Biopharma Corp
TKMR
0001628383
Murray Mark J.
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
President & CEO
Common Shares
2015-09-11
4
M
0
219428
0.4444
A
284389
D
Employee Stock Option (right to buy)
0.4444
2015-09-11
4
M
0
219428
0.0
D
2008-03-30
2015-09-12
Common shares
219428
0
D
Expressed in Canadian dollars.
/s/ Mark J. Murray
2015-09-15